NM_000851.4:c.*694T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000851.4(GSTM5):​c.*694T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.173 in 152,366 control chromosomes in the GnomAD database, including 2,421 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.17 ( 2417 hom., cov: 32)
Exomes 𝑓: 0.14 ( 4 hom. )

Consequence

GSTM5
NM_000851.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.657

Publications

43 publications found
Variant links:
Genes affected
GSTM5 (HGNC:4637): (glutathione S-transferase mu 5) Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase that belongs to the mu class. The mu class of enzymes functions in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of certain drugs. Diversification of these genes has occurred in regions encoding substrate-binding domains, as well as in tissue expression patterns, to accommodate an increasing number of foreign compounds. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.197 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000851.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GSTM5
NM_000851.4
MANE Select
c.*694T>C
3_prime_UTR
Exon 8 of 8NP_000842.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GSTM5
ENST00000256593.8
TSL:1 MANE Select
c.*694T>C
3_prime_UTR
Exon 8 of 8ENSP00000256593.3P46439
GSTM5
ENST00000966870.1
c.*694T>C
3_prime_UTR
Exon 10 of 10ENSP00000636929.1
GSTM5
ENST00000966873.1
c.*694T>C
3_prime_UTR
Exon 8 of 8ENSP00000636932.1

Frequencies

GnomAD3 genomes
AF:
0.173
AC:
26280
AN:
152032
Hom.:
2411
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.121
Gnomad AMI
AF:
0.419
Gnomad AMR
AF:
0.176
Gnomad ASJ
AF:
0.163
Gnomad EAS
AF:
0.134
Gnomad SAS
AF:
0.200
Gnomad FIN
AF:
0.192
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.200
Gnomad OTH
AF:
0.161
GnomAD4 exome
AF:
0.139
AC:
30
AN:
216
Hom.:
4
Cov.:
0
AF XY:
0.156
AC XY:
25
AN XY:
160
show subpopulations
African (AFR)
AF:
0.167
AC:
1
AN:
6
American (AMR)
AF:
0.00
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.250
AC:
2
AN:
8
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4
European-Finnish (FIN)
AF:
0.500
AC:
2
AN:
4
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
0.128
AC:
23
AN:
180
Other (OTH)
AF:
0.200
AC:
2
AN:
10
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.561
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.173
AC:
26306
AN:
152150
Hom.:
2417
Cov.:
32
AF XY:
0.173
AC XY:
12894
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.121
AC:
5020
AN:
41532
American (AMR)
AF:
0.177
AC:
2701
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.163
AC:
566
AN:
3470
East Asian (EAS)
AF:
0.134
AC:
694
AN:
5186
South Asian (SAS)
AF:
0.199
AC:
959
AN:
4820
European-Finnish (FIN)
AF:
0.192
AC:
2032
AN:
10578
Middle Eastern (MID)
AF:
0.153
AC:
45
AN:
294
European-Non Finnish (NFE)
AF:
0.200
AC:
13570
AN:
67966
Other (OTH)
AF:
0.160
AC:
338
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1104
2208
3313
4417
5521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.188
Hom.:
12296
Bravo
AF:
0.168
Asia WGS
AF:
0.169
AC:
589
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.74
DANN
Benign
0.65
PhyloP100
-0.66
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11807; hg19: chr1-110260742; API